4.6 Article

Impact of Adjuvant Therapy on Survival in Surgically Resected Limited-Stage Small Cell Lung Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Medicine, General & Internal

Small-cell lung cancer

Charles M. Rudin et al.

Summary: Small-cell lung cancer is a type of lung cancer characterized by high proliferative rate, early metastasis, and poor prognosis, strongly associated with tobacco carcinogens. Most patients are diagnosed with metastatic disease, with only a small fraction having potentially curative earlier-stage disease. Genomic profiling reveals extensive chromosomal rearrangements and high mutation burden in SCLC, often involving inactivation of TP53 and RB1 tumor suppressor genes.

NATURE REVIEWS DISEASE PRIMERS (2021)

Review Oncology

Surgery in Small-Cell Lung Cancer

Nicola Martucci et al.

Summary: Small-cell lung cancer (SCLC) is an aggressive tumor with limited response to chemotherapy and radiotherapy, but surgery may benefit selected early-stage patients. International guidelines recommend surgical intervention in selected stage I SCLC patients after proper evaluation.

CANCERS (2021)

Article Cardiac & Cardiovascular Systems

Predictors of survival following surgical resection of limited-stage small cell lung cancer

Nicolas Zhou et al.

Summary: The study highlights the survival benefit of adjuvant chemotherapy in limited-stage SCLC, but did not find a statistically significant influence from mediastinal PORT or PCI in the cohort. Larger prospective studies are needed to determine the benefits of PORT or PCI in a surgically resected limited-stage SCLC population.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2021)

Review Oncology

New Approaches to SCLC Therapy: From the Laboratory to the Clinic

John T. Poirier et al.

JOURNAL OF THORACIC ONCOLOGY (2020)

Article Oncology

Surgical Resection of SCLC: Prognostic Factors and the Tumor Microenvironment

Xiaoliang Zhao et al.

JOURNAL OF THORACIC ONCOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Survival after adjuvant radiation therapy in localized small cell lung cancer treated with complete resection

Kathryn E. Engelhardt et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2019)

Article Oncology

Development and Validation of a Nomogram Prognostic Model for SCLC Patients

Shidan Wang et al.

JOURNAL OF THORACIC ONCOLOGY (2018)

Review Oncology

Small-cell lung cancer: what we know, what we need to know and the path forward

Adi F. Gazdar et al.

NATURE REVIEWS CANCER (2017)

Article Cardiac & Cardiovascular Systems

Indications for Adjuvant Mediastinal Radiotherapy in Surgically Resected Small Cell Lung Cancer

Elliot Wakeam et al.

ANNALS OF THORACIC SURGERY (2017)

Article Multidisciplinary Sciences

Mutational signatures associated with tobacco smoking in human cancer

Ludmil B. Alexandrov et al.

SCIENCE (2016)

Article Oncology

Small Cell Lung Cancer

Gregory P. Kalemkerian et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2013)

Article Oncology

Small Cell Lung Cancer in Never Smokers Report of Two Cases

George K. Antony et al.

JOURNAL OF THORACIC ONCOLOGY (2010)